Sanofi regeneron

World French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States. 23 Jul 2019 01:25PM (Updated: 23 Jul 2019 01:30PM) Bookmark PARIS: French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States.The deal will give Sanofi exclusive U.S. over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu."This is a strategic and important transaction for us as we strive to continually bring innovations to the market," said Alan Main, executive vice president of Sanofi's consumer healthcare division, in a statement.(Reporting by Sudip Kar-Gupta; Editing by Subhranshu Sahu) … [Read more...] about Sanofi signs US rights deal with Roche for flu treatment Tamiflu

CAPE TOWN: South Africa's Biovac Institute will start local production of Sanofi's Hexavalent vaccine next year and Pfizer's anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.Local output of the two human vaccines is a step change for Biovac, a public-private partnership 47.5per cent-owned by the South African government with long-term ambitions of expanding sales into the continent.The new production lines follow years of technology transfers and skills upgrades with partners Sanofi and Pfizer in Africa's largest pharmaceutical market. The companies were tight-lipped about commercial details of the partnership."We start production of Hexavalent in Q3 2020," Morena Makhoana, Biovac's chief executive said at its state-of-the art facility in Cape Town.The plant, modernized at a cost of around 1 billion rand (US$70 million), will produce four million doses of Hexavalent vaccine a year and has capacity to ramp up significantly … [Read more...] about Pfizer, Sanofi, to boost South African Biovac’s vaccine output

Sanofi turns to Google in search for better treatments (Agence France-Presse) - June 18, 2019 - 3:38pm PARIS, France — French pharmaceutical firm Sanofi said Tuesday it is  partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments. The titan in online search "will apply technology and analytics on Sanofi’s large real world database to better understand what treatments work for patients," the pharmaceutical firm said in a statement. The use of Google's tools for deep analytics -- organising large amounts of data to make insights -- will help it better understand key diseases and patient outcomes to make further improvements. Sanofi will also be moving some of its business applications to Google's cloud computing platform and use artificial intelligence to improve operations. "Combining Sanofi’s biologic innovations and … [Read more...] about Sanofi turns to Google in search for better treatments

World French healthcare company Sanofi has teamed up with Google to work on innovations, aimed at using emerging data technologies to change how medicines and health services will be delivered in future. 18 Jun 2019 01:25PM Bookmark PARIS: French healthcare company Sanofi has teamed up with Google to work on innovations, aimed at using emerging data technologies to change how medicines and health services will be delivered in future.Sanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in a joint statement."Combining Sanofi's biologic innovations and scientific data with Google's industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies," said Ameet Nathwani, chief medical officer and executive vice-president, Sanofi.This would enable Sanofi to … [Read more...] about French drugmaker Sanofi, Google to use data tech for innovations